Form 4: Medifast CEO Daniel Chard Reports Stock Disposals for Tax Obligations

Daniel Chard, CEO of Medifast, reported the disposal of shares to cover withholding tax obligations related to the vesting of restricted stock units.

Summary

• Medifast CEO Daniel R. Chard reported the disposal of common stock shares on March 13, 16, and 17, 2025, to cover withholding tax obligations.
• A total of 5,001 shares were disposed of on March 13 at a price of $13.87.
• On March 16, 944 shares were disposed of at $13.94.
• On March 17, 1,864 shares were disposed of at $14.35.
• Following these transactions, Chard directly owns 51,293 shares of Medifast common stock.
• Chard also indirectly owns 149,317.352 shares through The Dan and Allyson Family Irrevocable Trust, for which he serves as Settlor and Investment Trustee.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock disposals for tax purposes, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track executive sentiment and potential alignment with shareholder interests.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in the CEO's holdings, but the disposals are for tax obligations and not indicative of a change in the CEO's confidence in the company.

Key Dates